Skip to content

Image -

Tobias Sjoblom.jpg

Tobias Sjöblom, professor at the Department of Immunology, Genetics and Pathology at Uppsala University.
Mikael Wallerstedt
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By:
Mikael Wallerstedt
File format:
.jpg
Size:
3562 x 2519, 1.05 MB
Download

Topics

Contacts

Related content

  • Genetic signatures provide prognostic information in colorectal cancer

    Using a unique collection of genetic and clinical data for colorectal cancer, researchers at Uppsala University have revealed genetic new alterations and developed of a new molecular classifier of tumour variants. The finding could lead to improved possibilities for individualised therapies. This is shown in study recently published in the journal Nature.

  • Genetic variation enhances cancer drug sensitivity

    By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against cancer cells in specific patient groups. This is shown in a recent study from Uppsala University, published in the journal eBiomedicine. The findings suggest a potential for more individually tailored and more effective cancer therapies.